Contact this trialFirst, we need to learn more about you.
Histone Deacetylase Inhibitor
Abexinostat + Pembrolizumab for Advanced Solid Tumor Malignancies
Recruiting1 awardPhase 1
San Francisco, California
This trial is testing abexinostat + pembrolizumab to treat participants with advanced MSI solid tumors. Abexinostat may stop tumor growth by blocking enzymes needed for cell growth. Pembrolizumab may stop tumor growth by interfering with the ability of tumor cells to grow and spread.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.